DGAP-News: MediClin AG: Dr. Ulrich Wandschneider shall become Chairman of the Supervisory Board of MediClin
(firmenpresse) - DGAP-News: MediClin AG / Key word(s): Change of Personnel
MediClin AG: Dr. Ulrich Wandschneider shall become Chairman of the
Supervisory Board of MediClin
12.04.2012 / 15:00
---------------------------------------------------------------------
Offenburg, April 12, 2012 - The Supervisory Board of MEDICLIN
Aktiengesellschaft (MediClin) decided to propose to the General Annual
Meeting, taking place on May 23, 2012, to elect Dr. Jochen Messemer,
Stephan Leonhard and Dr. Ulrich Wandschneider to the supervisory board.
Dr. Jochen Messemer runs for re-election after expiration of his mandate.
Stephan Leonhard was appointed by the court and should be elected by the
General Annual Meeting. Dr. Ulrich Wandschneider is recommended by the
majority shareholder Asklepios Kliniken Gesellschaft mit beschränkter
Haftung, Hamburg, to be elected to the supervisory board, after Dr. Jan
Boetius, supervisory board member and chairman of the supervisory board has
resigned as of May 31, 2012. The Supervisory Board has also decided to
propose Dr. Ulrich Wandschneider as candidate to become chairman of the
supervisory board, if elected to the supervisory board, based on his
industry experience for many years and in view of his function as Chairman
of Corporate Management of the Asklepios-Group.
Dr. Ulrich Wandschneider has resigned as Board Member of the Management
Board of MediClin as of May 31, 2012.
Jens Breuer, future CFO of MediClin, will take office already as of June
1st, 2012.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungs-zentren (medical care units) in 11 federal states MediClin has
a total capacity of approximately 8,100 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,300 employees.
End of Corporate News
---------------------------------------------------------------------
12.04.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr(at)mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
164695 12.04.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Vena Resources: Candelaria Silver files Preliminary Prospectus
Datum: 12.04.2012 - 09:00 Uhr
Sprache: Deutsch
News-ID 1102363
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 108 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MediClin AG: Dr. Ulrich Wandschneider shall become Chairman of the Supervisory Board of MediClin
"
steht unter der journalistisch-redaktionellen Verantwortung von
MediClin AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
